Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen.

Estrogen exerts profound effects on mood and mental state. The ability of estrogen to modulate serotonergic function raises the possibility that it may play a role in the mechanism associated with depression and its treatment. A cellular mechanism for estrogen to influence mood might be through the regulation of genes involved at various levels of the serotonin system. Here we report that estrogen can up-regulate the expression of the serotonin-1A receptor via a new mechanism involving synergistic activation by nuclear factor-kappa B (NF-kappa B) with estrogen receptor alpha. Interestingly, we observed that only estrogen receptor-alpha, and not -beta, was able to mediate this effect of estrogens. The partial antiestrogen, 4-hydroxytamoxifen, had the same effect as estrogen. In addition, mutation analysis showed that both the transactivation function of p65 and activation function 1 of estrogen receptor-alpha were essential for this synergistic regulation. Therefore, we propose that NF-kappa B complexes cooperate with estrogen receptor-alpha to recruit cofactors into the complex and thereby synergistically activate the serotonin-1A receptor promoter through nonclassical estrogen response elements by a mechanism that does not involve direct receptor binding to DNA.

[1]  H. Pols,et al.  Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability. , 1999, Biochemical and biophysical research communications.

[2]  B. McEwen,et al.  Estrogen actions in the central nervous system. , 1999, Endocrine reviews.

[3]  V. Giguère,et al.  Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. , 1999, Molecular cell.

[4]  A D Vethaak,et al.  Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  L. Cohen,et al.  Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? , 1998, Biological Psychiatry.

[6]  G. Fink,et al.  SEX STEROID CONTROL OF MOOD, MENTAL STATE AND MEMORY , 1998, Clinical and experimental pharmacology & physiology.

[7]  N. Weigel,et al.  Ligand-independent activation of steroid hormone receptors , 1998, Journal of Molecular Medicine.

[8]  P. Shughrue,et al.  Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system , 1997, The Journal of comparative neurology.

[9]  L. Koenderman,et al.  NF-κB/Rel Family Members Regulating the ICAM-1 Promoter in Monocytic THP-1 Cells , 1997 .

[10]  E. Kalkhoven,et al.  Distinct Domains of the RelA NF-κB Subunit Are Required for Negative Cross-talk and Direct Interaction with the Glucocorticoid Receptor* , 1997, The Journal of Biological Chemistry.

[11]  C. Kaltschmidt,et al.  NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.

[12]  M. Buhot Serotonin receptors in cognitive behaviors , 1997, Current Opinion in Neurobiology.

[13]  B. Spiegelman,et al.  Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ , 1996, Science.

[14]  A. Israël,et al.  NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.

[15]  T. García,et al.  Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens. , 1996, Molecular endocrinology.

[16]  M. Elgort,et al.  Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence. , 1996, Molecular endocrinology.

[17]  J. Studd,et al.  Transdermal oestrogen for treatment of severe postnatal depression , 1996, The Lancet.

[18]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[19]  B Stein,et al.  Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.

[20]  G. McNeil,et al.  Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins. , 1995, Molecular endocrinology.

[21]  P. Webb,et al.  Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. , 1995, Molecular endocrinology.

[22]  J. Gustafsson,et al.  Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. , 1995, Molecular endocrinology.

[23]  S. Safe,et al.  Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. , 1994, The Journal of biological chemistry.

[24]  A. Ray,et al.  Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. , 1994, The Journal of biological chemistry.

[25]  B. Katzenellenbogen,et al.  Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. , 1994, The Journal of biological chemistry.

[26]  J. Lees,et al.  Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.

[27]  M. Pompeiano,et al.  Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  S. Watson,et al.  Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic study , 1991, Brain Research.

[29]  K. Korach,et al.  The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. , 1991, Endocrinology.

[30]  D. Murphy,et al.  Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[31]  Stephan Gebel,et al.  Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.

[32]  U. Halbreich Psychiatric disorders associated with specific periods in women's lives. , 1990, The American journal of psychiatry.

[33]  H. V. Van Tol,et al.  Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. , 1990, The Journal of biological chemistry.

[34]  N. Webster,et al.  The human estrogen receptor has two independent nonacidic transcriptional activation functions , 1989, Cell.

[35]  M. Caron,et al.  Effector coupling mechanisms of the cloned 5-HT1A receptor. , 1989, The Journal of biological chemistry.

[36]  M. Blankenstein,et al.  Mitogenic stimulation of human breast cancer cells in a growth factor‐defined medium: Synergistic action of insulin and estrogen , 1988, Journal of cellular physiology.

[37]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[38]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[39]  G. Oppenheim Estrogen in the treatment of depression: neuropharmacological mechanisms. , 1983, Biological psychiatry.

[40]  B. McEwen,et al.  Modulation by estradiol of serotonin receptors in brain , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  B. Katzenellenbogen,et al.  Transcription Activation by the Human Estrogen Receptor Subtype b ( ER b ) Studied with ER b and ER a Receptor Chimeras * , 1998 .

[42]  G. Fink,et al.  Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. , 1997, Brain research. Molecular brain research.

[43]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[44]  J. Polman,et al.  ER beta: identification and characterization of a novel human estrogen receptor. , 1996, FEBS letters.

[45]  Maria X. Yang Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF- (cid:107) B and C/EBP (cid:98) , 1995 .

[46]  M. Tzukerman,et al.  Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. , 1994, Molecular endocrinology.

[47]  D. Julius Molecular biology of serotonin receptors. , 1991, Annual review of neuroscience.

[48]  J. Lehmann,et al.  Nuclear retinoic acid receptors: cloning, analysis, and function. , 1990, Methods in enzymology.

[49]  K. Lesch,et al.  [The serotonin hypothesis of depression]. , 1990, Fortschritte der Neurologie-Psychiatrie.

[50]  J. Gustafsson,et al.  Cloning of a novel estrogen receptor expressed in rat prostate and ovary , 2022 .